| Amber Kyle, PHARMD, BCCCP | |
|
7930 Marshall Dr, Lenexa, KS 66214-1562 | |
| (866) 451-8804 | |
| (913) 451-8914 |
| Full Name | Amber Kyle |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7930 Marshall Dr, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750989455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-14794 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber Kyle, PHARMD, BCCCP 7930 Marshall Dr, Lenexa, KS 66214-1562 Ph: (866) 451-8804 | Amber Kyle, PHARMD, BCCCP 7930 Marshall Dr, Lenexa, KS 66214-1562 Ph: (866) 451-8804 |
News Archive
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
As part of his newfound assertiveness, President Obama is using the term "Obamacare," the Republicans' sneering dismissal of the Democratic health care reforms. We are skeptical that he will be able to turn it into a term of approbation. But it is heartening to see him finally out there defending his pioneering policy with no apologies and an uncharacteristic feistiness.
A study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients could have saved lives, according to the University of Huddersfield researchers involved.
Researchers in the United States have estimated that the proportion of people in New York City who developed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the coronavirus disease 2019 (COVID-19) pandemic is around one in eight.
PTC Therapeutics, Inc., the SMA Foundation, and Roche, announced today that their joint research program in Spinal Muscular Atrophy has entered the first stage of clinical development aiming to assess safety and tolerability of an oral compound in healthy volunteers.
› Verified 8 days ago
Jacob Thomas Stolz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15100 W 87th Street Pkwy, Lenexa, KS 66219 Phone: 913-438-5172 | |
Katy Dolinar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13400 W 87th Street Pkwy, Lenexa, KS 66215 Phone: 913-438-6651 | |
Christopher Shane Slifer, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11131 W 79th St, Lenexa, KS 66214 Phone: 913-234-4664 Fax: 913-234-4665 | |
Jill Ann Ottinger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11131 W 79th St, Lenexa, KS 66214 Phone: 913-234-4664 | |
Jerald E. Bowmer, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17301 W 84th Ter, Lenexa, KS 66219 Phone: 913-530-1493 Fax: 913-599-5435 | |
Ms. Elaine Carol Clancy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11162 Renner Blvd, Lenexa, KS 66219 Phone: 800-360-0520 | |
Jonathan Fernandez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10050 Woodland Dr, Lenexa, KS 66220 Phone: 913-397-0906 Fax: 913-397-0332 |